Table 1.

PICOS eligibility criteria.

Population	Those at risk of cardiovascular disease
Intervention	Statin or anti-inflammatory therapy that decreases CRP
Comparison	Placebo or statin/ anti-inflammatory comparator
Outcome	Major adverse cardiovascular events
Study design	Randomised controlled trials